Person · CIK 1315082
RA CAPITAL MANAGEMENT, L.P.
Fetching the filing list from SEC EDGAR. This page refreshes on its own.
Recent filings so far
25 recent filings already on SEC Tracker. The full history, totals and holdings follow when the read from SEC EDGAR finishes.
| Filed | Form | Company | Summary |
|---|---|---|---|
| 2026-11-03 | 4 | Bambusa Therapeutics, Inc. (BBTX) | |
| 2026-11-02 | 4 | LENZ Therapeutics, Inc. (LENZ) | RA CAPITAL MANAGEMENT, L.P. (10% owner) sold 2,718,684 LENZ at $3.36, worth $9.1M |
| 2026-10-29 | 3 | RA Capital Healthcare Fund LP | Bambusa Therapeutics, Inc. reports ownership |
| 2026-10-07 | 4 | Wave Life Sciences, Inc. (WVE) | Wave Life Sciences, Inc. (WVE) reports insider transactions. |
| 2026-10-05 | 4 | Vor Biopharma Inc. (VOR) | VOR: Kolchinsky Peter files Form 4 |
| 2026-09-30 | 4 | Climb Bio, Inc. (CLYM) | |
| 2026-09-21 | 4 | Sionna Therapeutics, Inc. (SION) | |
| 2026-09-17 | 144 | Sionna Therapeutics, Inc. (SION) | |
| 2026-09-17 | 4 | Tyra Biosciences, Inc. (TYRA) | |
| 2026-09-14 | 4 | Artiva Biotherapeutics, Inc. (ARTV) | |
| 2026-09-08 | 4 | Artiva Biotherapeutics, Inc. (ARTV) | |
| 2026-08-26 | 4 | Vor Biopharma Inc. (VOR) | |
| 2026-08-14 | 4 | Septerna, Inc. (SEPN) | |
| 2026-08-12 | 144 | Septerna, Inc. (SEPN) | |
| 2026-07-31 | 4 | Artiva Biotherapeutics, Inc. (ARTV) | |
| 2026-07-31 | 4 | Inhibikase Therapeutics, Inc. (IKT) | |
| 2026-07-28 | 4 | Artiva Biotherapeutics, Inc. (ARTV) | |
| 2026-07-23 | 4 | Artiva Biotherapeutics, Inc. (ARTV) | |
| 2026-07-23 | 4/A | Artiva Biotherapeutics, Inc. (ARTV) | |
| 2026-07-22 | 4 | Freenome, Inc. (FRNM) | |
| 2026-07-22 | 3 | Freenome, Inc. (FRNM) | |
| 2026-07-22 | 4 | Parabilis Medicines, Inc. (PBLS) | |
| 2026-07-21 | 4 | Vor Biopharma Inc. (VOR) | |
| 2026-07-20 | 4 | Artiva Biotherapeutics, Inc. (ARTV) | |
| 2026-07-17 | 3 | Inhibikase Therapeutics, Inc. (IKT) |
Every figure is as filed with the SEC on Forms 3, 4, 5 and 144. Holdings are the amounts reported after each person's latest filing at each company and can be out of date. Matching a Form 144 notice to Form 4 sales is SEC Tracker's inference from owner, company, dates and share counts, not something the filings state. Not investment advice. Not affiliated with the U.S. SEC.